Experimental drugs for breast cancer could treat lung cancer too

August 13, 2013, Cancer Research UK
Experimental drugs for breast cancer could treat lung cancer too

Cancer Research UK -funded scientists have discovered that experimental drugs first developed for breast and ovarian cancer could be used to treat the most common type of lung cancer, reveals research published in Oncogene today.

The study, led by scientists at The Institute of Cancer Research, London, showed how experimental drugs called PARP inhibitors could be useful in up to half of non-small-cell lung cancer (NSCLC) tumours with a fault in one of the ways cells repair damage to their DNA.

Adding PARP inhibitors to these damages a second DNA damage repair system. This double blow kills the lung cancer cells, but leaves healthy cells unscathed.

Lung cancer is the most common cause of in the UK accounting for more than a fifth of all cancer deaths. More than eight out of 10 cases of lung cancer are – more than 33,000 cases per year in the UK.

There are very few treatment options for patients with lung cancer. The few that are available have a limited effect, and there is an urgent need for new treatments.

Study author Dr Chris Lord, a Cancer Research-UK funded scientist at The Institute of Cancer Research (ICR), said: "This study suggests that PARP inhibitors – treatments already in clinical trials to treat breast and – could also be a promising treatment for patients with certain forms of lung cancer.

"Lung cancer is hard to treat and unfortunately has very poor survival – so there's an urgent need to find new treatments. Our research opens up an exciting new route, by showing how we could repurpose drugs originally designed for use against other forms of cancer. We now need to build on this promising early research by testing PARP inhibitors against lung cancer in clinical trials to confirm whether they can benefit patients."

Dr Harpal Kumar, Cancer Research UK's chief executive, said: "Lung cancer is the UK's biggest cancer killer but it's proven to be one of the hardest cancers to study and survival rates remain poor.

"We're making substantial investments in lung cancer research to discover better ways to diagnose and treat the disease. Our hope is that studies like this will lead to more effective treatments for patients and ultimately save more lives."

Explore further: Genetic screen finds new treatment targets for lung cancer

More information: Lord et al., A high-throughput Screen Identifies PARP1/2 Inhibitors as a Potential Therapy for ECC1-Deficient Non-Small Cell Lung Cancer (2013) Oncogene DOI: 10.1038/onc.2013.311

Related Stories

Genetic screen finds new treatment targets for lung cancer

July 9, 2013
Cancer Research UK scientists are the first to use an efficient new screening strategy to identify gene faults in tumour cells that are possible drug targets for the most common form of lung cancer, according to new research ...

Novel therapeutic targets identified for small cell lung cancer

September 6, 2012
Newly discovered molecular differences between small cell lung cancer and nonsmall cell lung cancer have revealed PARP1 and EZH2 as potential therapeutic targets for patients with small cell lung cancer, according to the ...

Diabetes drug makes lung cancer vulnerable to radiotherapy

May 1, 2013
The diabetes drug metformin slows the growth of lung cancer cells and makes them more likely to be killed by radiotherapy, according to a study published in the British Journal of Cancer today.

Кesearchers identify gene variations that may help predict cancer treatment response

August 9, 2013
Researchers at the Moffitt Cancer Center have identified four inherited genetic variants in non-small cell lung cancer patients that can help predict survival and treatment response. Their findings could help lead to more ...

FDA approves genetic test for lung cancer drug

May 14, 2013
The Food and Drug Administration says it approved a genetic test from Roche to help doctors identify patients who can benefit from a lung cancer drug made by Genentech.

Renewed hope in a once-abandoned cancer drug class

June 19, 2013
Could drugs that block the body's system for repairing damage to the genetic material DNA become a boon to health? As unlikely as it may seem, those compounds are sparking optimism as potential treatments for ovarian and ...

Recommended for you

How cancer metastasis happens: Researchers reveal a key mechanism

January 18, 2018
Cancer metastasis, the migration of cells from a primary tumor to form distant tumors in the body, can be triggered by a chronic leakage of DNA within tumor cells, according to a team led by Weill Cornell Medicine and Memorial ...

Modular gene enhancer promotes leukemia and regulates effectiveness of chemotherapy

January 18, 2018
Every day, billions of new blood cells are generated in the bone marrow. The gene Myc is known to play an important role in this process, and is also known to play a role in cancer. Scientists from the German Cancer Research ...

These foods may up your odds for colon cancer

January 18, 2018
(HealthDay)—Chowing down on red meat, white bread and sugar-laden drinks might increase your long-term risk of colon cancer, a new study suggests.

The pill lowers ovarian cancer risk, even for smokers

January 18, 2018
(HealthDay)—It's known that use of the birth control pill is tied to lower odds for ovarian cancer, but new research shows the benefit extends to smokers or women who are obese.

Researchers develop swallowable test to detect pre-cancerous Barrett's esophagus

January 17, 2018
Investigators at Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Center have developed a simple, swallowable test for early detection of Barrett's esophagus that offers promise ...

Scientists zoom in to watch DNA code being read

January 17, 2018
Scientists have unveiled incredible images of how the DNA code is read and interpreted—revealing new detail about one of the fundamental processes of life.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.